- Pack/Packs
- 2
- Pack/Packs
- 40000 INR
- Store below 30C
- Regorafenib (40mg)
- Tablet
- In Cancer of colon and rectum
BENEFITS OF RESIHANCE TABLET
In Cancer of colon and rectum
Cancer of the colon and rectum, also known as colorectal cancer (CRC) or bowel cancer, is the development of cancer from two parts of the large intestine, namely, the colon or rectum. In this type of cancer, the person may notice symptoms such as blood in the stool, a change in bowel movements, weight loss, and fatigue. Resihance 40mg Tablet treats and also lowers the risk of developing further cancerous growths (polyps) and bowel cancer. It kills or stops the growth of cancer cells and also prevents the multiplication of cancer cells. It is an effective, yet very toxic medicine and you should discuss the risks and benefits with your doctor. Avoid drinking alcohol or smoking while having this treatment and drink plenty of water to stay hydrated.
Product details
Composition | Regorafenib |
Packaging Size | 28 Tab / Bottle |
Available Strength | 40mg |
Product Type | Tablet |
Therapeutics Use | Treatment of cancer of colon and rectum. |
Manufactured By | Zydus Cadila |
- 1000 Per Week
- 7-60 Days
- Africa, Middle East, Western Europe, Eastern Europe, South America, North America, Central America, Australia, Asia
B No. 155/156/157, New Sardar Trade Market, APMC Building, Puna Kumbhariya Road, Surat, Gujarat, 395010, India
Phone :07201811820